Metabolic  ||| S:0 E:10 ||| NNP
and  ||| S:10 E:14 ||| CC
organ  ||| S:14 E:20 ||| JJ
protective  ||| S:20 E:31 ||| JJ
properties  ||| S:31 E:42 ||| NNS
of  ||| S:42 E:45 ||| IN
various  ||| S:45 E:53 ||| JJ
infusion  ||| S:53 E:62 ||| NN
solutions  ||| S:62 E:72 ||| NNS
and  ||| S:72 E:76 ||| CC
the  ||| S:76 E:80 ||| DT
choice  ||| S:80 E:87 ||| NN
of  ||| S:87 E:90 ||| IN
starting  ||| S:90 E:99 ||| VBG
therapy  ||| S:99 E:107 ||| NN
in  ||| S:107 E:110 ||| IN
the  ||| S:110 E:114 ||| DT
pre-admission  ||| S:114 E:128 ||| JJ
stage  ||| S:128 E:134 ||| NN
of  ||| S:134 E:137 ||| IN
acetic  ||| S:137 E:144 ||| JJ
acid  ||| S:144 E:149 ||| NN
poisoning  ||| S:149 E:159 ||| VBD
We  ||| S:159 E:162 ||| PRP
conducted  ||| S:162 E:172 ||| VBD
an  ||| S:172 E:175 ||| DT
open  ||| S:175 E:180 ||| JJ
prospective  ||| S:180 E:192 ||| JJ
study  ||| S:192 E:198 ||| NN
in  ||| S:198 E:201 ||| IN
60  ||| S:201 E:204 ||| CD
patients  ||| S:204 E:213 ||| NNS
( ||| S:213 E:214 ||| -LRB-
30  ||| S:214 E:217 ||| CD
men  ||| S:217 E:221 ||| NNS
and  ||| S:221 E:225 ||| CC
30  ||| S:225 E:228 ||| CD
women ||| S:228 E:233 ||| NNS
)  ||| S:233 E:235 ||| -RRB-
with  ||| S:235 E:240 ||| IN
acetic  ||| S:240 E:247 ||| JJ
acid  ||| S:247 E:252 ||| NN
poisoning ||| S:252 E:261 ||| NN
.  ||| S:261 E:263 ||| .
A  ||| S:263 E:265 ||| DT
randomization  ||| S:265 E:279 ||| NN
was  ||| S:279 E:283 ||| VBD
performed  ||| S:283 E:293 ||| VBN
on  ||| S:293 E:296 ||| IN
the  ||| S:296 E:300 ||| DT
groups ||| S:300 E:306 ||| NNS
,  ||| S:306 E:308 ||| ,
taking  ||| S:308 E:315 ||| VBG
into  ||| S:315 E:320 ||| IN
account  ||| S:320 E:328 ||| NN
the  ||| S:328 E:332 ||| DT
tactics  ||| S:332 E:340 ||| NNS
of  ||| S:340 E:343 ||| IN
infusion  ||| S:343 E:352 ||| JJ
therapy ||| S:352 E:359 ||| NN
:  ||| S:359 E:361 ||| :
group  ||| S:361 E:367 ||| NN
I--15  ||| S:367 E:373 ||| CD
patients  ||| S:373 E:382 ||| NNS
who  ||| S:382 E:386 ||| WP
did  ||| S:386 E:390 ||| VBD
not  ||| S:390 E:394 ||| RB
receive  ||| S:394 E:402 ||| VB
an  ||| S:402 E:405 ||| DT
infusion  ||| S:405 E:414 ||| NN
therapy  ||| S:414 E:422 ||| NN
at  ||| S:422 E:425 ||| IN
a  ||| S:425 E:427 ||| DT
pre-admission  ||| S:427 E:441 ||| JJ
stage ||| S:441 E:446 ||| NN
;  ||| S:446 E:448 ||| :
group  ||| S:448 E:454 ||| NN
II--15  ||| S:454 E:461 ||| CD
patients  ||| S:461 E:470 ||| NNS
who  ||| S:470 E:474 ||| WP
received  ||| S:474 E:483 ||| VBD
the  ||| S:483 E:487 ||| DT
infiusion  ||| S:487 E:497 ||| JJ
therapy  ||| S:497 E:505 ||| NN
with  ||| S:505 E:510 ||| IN
solution  ||| S:510 E:519 ||| NN
of  ||| S:519 E:522 ||| IN
sodium  ||| S:522 E:529 ||| JJ
chloride  ||| S:529 E:538 ||| NN
0.9 ||| S:538 E:541 ||| CD
% ||| S:541 E:542 ||| NN
;  ||| S:542 E:544 ||| :
group  ||| S:544 E:550 ||| NN
III--15  ||| S:550 E:558 ||| CD
patients  ||| S:558 E:567 ||| NNS
who  ||| S:567 E:571 ||| WP
received  ||| S:571 E:580 ||| VBD
the  ||| S:580 E:584 ||| DT
infusion  ||| S:584 E:593 ||| NN
therapy  ||| S:593 E:601 ||| NN
with  ||| S:601 E:606 ||| IN
modified  ||| S:606 E:615 ||| JJ
gelatin  ||| S:615 E:623 ||| NNS
( ||| S:623 E:624 ||| -LRB-
Gelofusinwn ||| S:624 E:635 ||| NNP
) ||| S:635 E:636 ||| -RRB-
,  ||| S:636 E:638 ||| ,
group  ||| S:638 E:644 ||| NN
IV-15  ||| S:644 E:650 ||| CD
patients  ||| S:650 E:659 ||| NNS
who  ||| S:659 E:663 ||| WP
received  ||| S:663 E:672 ||| VBD
the  ||| S:672 E:676 ||| DT
infusion  ||| S:676 E:685 ||| NN
therapy  ||| S:685 E:693 ||| NN
with  ||| S:693 E:698 ||| IN
reamberinum ||| S:698 E:709 ||| NN
.  ||| S:709 E:711 ||| .
We  ||| S:711 E:714 ||| PRP
found  ||| S:714 E:720 ||| VBD
that  ||| S:720 E:725 ||| IN
the  ||| S:725 E:729 ||| DT
most  ||| S:729 E:734 ||| RBS
favorable  ||| S:734 E:744 ||| JJ
results  ||| S:744 E:752 ||| NNS
were  ||| S:752 E:757 ||| VBD
noted  ||| S:757 E:763 ||| VBN
in  ||| S:763 E:766 ||| IN
patients  ||| S:766 E:775 ||| NNS
of  ||| S:775 E:778 ||| IN
group  ||| S:778 E:784 ||| NN
IV  ||| S:784 E:787 ||| NNP
in  ||| S:787 E:790 ||| IN
the  ||| S:790 E:794 ||| DT
early  ||| S:794 E:800 ||| JJ
posttraumatic  ||| S:800 E:814 ||| JJ
period ||| S:814 E:820 ||| NN
.  ||| S:820 E:822 ||| .
